With its potential to treat an enormous range of diseases, genetic medicine has become a focal point for many large drug companies. Novartis, for instance, …
A crucial study evaluating Biogen’s approved drug for Alzheimer’s disease is set to begin in May, the company disclosed Thursday, and if enrollment goes as …
Early in the spring of 2020, Immunomedics was waiting for the Food and Drug Administration to decide on accelerated approval of the company’s breast cancer …
Final trial data for molnupiravir were less convincing than what Merck previously reported and could alter how the FDA views the drug. New study results …
Aduhelm has come under intense scrutiny since the Food and Drug Administration’s controversial June approval of the drug, the first new Alzheimer’s treatment in decades …
The Food and Drug Administration on Friday authorized COVID-19 booster shots for all vaccinated Americans over 18, a move that’s meant to stem a rise …
The decision affects Medicare Part B, which pays for health care services typically received outside of institutional settings like hospitals and nursing homes. The planned …
Amylyx Pharmaceuticals has officially asked the Food and Drug Administration to approve its experimental and closely watched medicine for ALS. Now, the FDA has around …
U.K. regulators have once again moved faster than the Food and Drug Administration to approve a new medicine for COVID-19. The UK’s Medicines and Healthcare …
Merck’s pill has the potential to alter the course of the pandemic. Earlier this month, the company and partner Ridgeback Biotherapeutics released data showing molnupiravir …
This is the first time government advisers have recommended routine use of a pneumococcal vaccine for certain risk groups within the 19-64 age bracket, a …
Peter Marks, one of the Food and Drug Administration’s top-ranking officials, has taken over the agency’s vaccine review office just as the regulator begins considering …
Before J&J become one of three companies that earned Food and Drug Administration approval for a coronavirus vaccine, the pharma was already a leader in …
The Food and Drug Administration on Monday granted full approval to Pfizer and BioNTech’s coronavirus vaccine, a long-awaited decision that government officials hope could help …
